NSE - Free Realtime Quote INR

Advanced Enzyme Technologies Limited (ADVENZYMES.NS)

Compare
340.35
-6.05
(-1.75%)
As of 3:21:02 PM GMT+5:30. Market Open.
Loading Chart for ADVENZYMES.NS
DELL
  • Previous Close 346.40
  • Open 347.60
  • Bid 340.30 x --
  • Ask 340.50 x --
  • Day's Range 337.90 - 347.60
  • 52 Week Range 334.05 - 571.00
  • Volume 211,323
  • Avg. Volume 234,801
  • Market Cap (intraday) 38.079B
  • Beta (5Y Monthly) 0.40
  • PE Ratio (TTM) 27.76
  • EPS (TTM) 12.26
  • Earnings Date Feb 8, 2025 - Feb 12, 2025
  • Forward Dividend & Yield 5.10 (1.47%)
  • Ex-Dividend Date Jul 18, 2024
  • 1y Target Est 470.00

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications, biofuels, and bio-catalysis. It provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is based in Thane, India.

www.advancedenzymes.com

323

Full Time Employees

March 31

Fiscal Year Ends

Recent News: ADVENZYMES.NS

View More

Performance Overview: ADVENZYMES.NS

Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

ADVENZYMES.NS
1.19%
S&P BSE SENSEX
1.21%

1-Year Return

ADVENZYMES.NS
5.89%
S&P BSE SENSEX
8.29%

3-Year Return

ADVENZYMES.NS
4.88%
S&P BSE SENSEX
29.39%

5-Year Return

ADVENZYMES.NS
109.49%
S&P BSE SENSEX
86.48%

Compare To: ADVENZYMES.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ADVENZYMES.NS

View More

Valuation Measures

As of 1/9/2025
  • Market Cap

    38.76B

  • Enterprise Value

    34.00B

  • Trailing P/E

    28.28

  • Forward P/E

    20.24

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.26

  • Price/Book (mrq)

    2.89

  • Enterprise Value/Revenue

    5.49

  • Enterprise Value/EBITDA

    14.91

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    22.13%

  • Return on Assets (ttm)

    7.00%

  • Return on Equity (ttm)

    10.47%

  • Revenue (ttm)

    6.19B

  • Net Income Avi to Common (ttm)

    1.37B

  • Diluted EPS (ttm)

    12.26

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.07B

  • Total Debt/Equity (mrq)

    3.38%

  • Levered Free Cash Flow (ttm)

    679.22M

Research Analysis: ADVENZYMES.NS

View More

People Also Watch